International Patent: INJECTABLE COMPOSITIONS COMPOSED OF A STATIN, AN ANTI-CANCER AGENT, OR A COMBINATION THEREOF FOR REDUCING OR PREVENTING BLOOD FLOW IN A NEUROVASCULAR VESSEL

GENEVA, Aug. 31 -- FLUIDX MEDICAL TECHNOLOGY, INC. filed a patent application (US2026/014859) for “INJECTABLE COMPOSITIONS COMPOSED OF A STATIN, AN ANTI-CANCER AGENT, OR A COMBINATION THEREOF FOR REDUCING OR PREVENTING BLOOD FLOW IN A NEUROVASCULAR VESSEL”. With publication no. WO/2026/177925, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61L 24/06

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....